4.3 Article

Frailty is associated with poor prognosis after resection for pancreatic cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Aging, cancer, and antitumor immunity

Hideki Ikeda et al.

Summary: Aging leads to changes in the immune system, causing dysregulated responses and increased susceptibility to diseases in elderly individuals. Despite some understanding, detailed mechanisms of immunosenescence remain unclear. ICIs have shown efficacy in older cancer patients, but may be less effective in very old patients with more frequent toxicities.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Prognostic Value of the Preoperative Tumor Marker Index in Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Institution Study

Tatsunori Miyata et al.

Summary: The pre-TI is an independent adverse prognostic factor predicting the relapse-free survival and overall survival of PDAC patients undergoing resection.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer

Yueming Zhang et al.

Summary: Preoperative blood glucose to lymphocyte ratio serves as an independent biomarker for predicting overall survival in patients with pancreatic ductal adenocarcinoma following curative resection, particularly showing prognostic value in specific patient subgroups.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study)

Tomoko Hamaya et al.

Summary: This study found a significant association between baseline frailty and HRQOL in prostate cancer patients, as well as significant differences in baseline frailty and HRQOL between localized and metastatic diseases. Frailty was associated with worse quality of life in patients with PC.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Prognostic value of the Memorial Sloan Kettering Prognostic Score in metastatic pancreatic adenocarcinoma

Justin M. Lebenthal et al.

Summary: The Memorial Sloan Kettering Prognostic Score (MPS), consisting of the neutrophil-lymphocyte ratio (NLR) and albumin levels, is a predictive tool for survival in patients with metastatic pancreatic adenocarcinoma (mPDAC) regardless of performance status, disease characteristics, and cancer therapy. Higher MPS scores, liver metastases, radiation therapy, hospital admissions, thromboembolism, and performance status were associated with worse overall survival in this study.

CANCER (2021)

Article Oncology

Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)

Yoichi Naito et al.

Summary: The study revised the Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment released in 2017, with two parts: explanation of cancer genomic profiling test and clinical questions in practice. The emphasis is on healthcare professionals considering the patient's overall condition and organ function when selecting patients for genomic testing to determine if they can tolerate drug therapy.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

Taiga Otsuka et al.

Summary: The study found that FFX and GnP have comparable efficacy, but different safety profiles, which should be taken into consideration when selecting treatment.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Oncology

Survival benefit of adjuvant chemotherapy in elderly patients with colon cancer: a systematic review and meta-analysis

Nobuaki Hoshino et al.

Summary: Adjuvant chemotherapy provides a significant survival benefit for elderly patients with colon cancer, with significantly higher 5-year overall survival rate and improved overall survival. However, the evidence quality for this benefit in elderly patients is low.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy

Tsuyoshi Takeda et al.

Summary: Cachexia and sarcopenia significantly impact the clinical course of elderly pancreatic cancer patients undergoing chemotherapy, with cachexia being a more predictive factor while sarcopenia has a lesser effect on patients' clinical outcomes.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Critical Care Medicine

Frailty status among older critically ill patients with severe acute kidney injury

William Beaubien-Souligny et al.

Summary: Pre-existing frailty is an independent risk factor for mortality among older critically ill patients with severe AKI. A substantial proportion of survivors experience declining function and worsened frailty status within one year.

CRITICAL CARE (2021)

Article Oncology

Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients

Tsuyoshi Takeda et al.

Summary: In patients with pancreatic cancer (PC) treated with gemcitabine plus nab-paclitaxel (GnP), the incidence of drug-induced interstitial lung disease (ILD) was 2.2%. Patients recovered from ILD, and overall survival (OS) did not differ based on ILD occurrence. Blood type B was identified as an independent risk factor for developing ILD.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Gastroenterology & Hepatology

Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma

Keinosuke Ishido et al.

Summary: Pancreatic ductal adenocarcinoma is a highly malignant tumor with a low 5-year survival rate. Multidisciplinary approaches, including non-surgical treatments, have led to gradual improvement in prognosis. Early detection, comprehensive treatment options such as surgery and chemotherapy, and ongoing research are crucial in improving outcomes for PDAC patients.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2021)

Review Oncology

From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer

Christopher Nevala-Plagemann et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Article Gastroenterology & Hepatology

Microbiota in pancreatic health and disease: the next frontier in microbiome research

Ryan M. Thomas et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Oncology

The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities

Won Jin Ho et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Review Gastroenterology & Hepatology

Prehabilitation prior to surgery for pancreatic cancer: A systematic review

James R. Bundred et al.

PANCREATOLOGY (2020)

Article Gastroenterology & Hepatology

Frailty is an independent risk factor for recurrence and mortality following curative resection of stage I-III colorectal cancer

Kosuke Mima et al.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)

Review Gastroenterology & Hepatology

History of pancreatic surgery in Japan: Respect to the Japanese pioneers of pancreatic surgery

Hiroki Yamaue

ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)

Review Gastroenterology & Hepatology

Neoadjuvant treatment for resectable pancreatic adenocarcinoma: What is the best protocol?

Fuyuhiko Motoi et al.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)

Review Gastroenterology & Hepatology

Molecular subtypes of pancreatic cancer

Eric A. Collisson et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Oncology

Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update

Alok A. Khorana et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Review Oncology

Optimizing the outcomes of pancreatic cancer surgery

Oliver Strobel et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Article Oncology

Physical activity and exercise during preoperative pancreatic cancer treatment

Nathan H. Parker et al.

SUPPORTIVE CARE IN CANCER (2019)

Article Oncology

Frailty and Cancer: Implications for Oncology Surgery, Medical Oncology, and Radiation Oncology

Cecilia G. Ethun et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Article Cardiac & Cardiovascular Systems

Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement

Tetsuro Shimura et al.

CIRCULATION (2017)

Article Geriatrics & Gerontology

Impact of an oncogeriatric consulting team on therapeutic decision-making

M. E. Rouge-Bugat et al.

JOURNAL OF NUTRITION HEALTH & AGING (2013)

Article Medicine, General & Internal

Frailty in elderly people

Andrew Clegg et al.

LANCET (2013)

Article Medicine, General & Internal

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Surgery

The Clavien-Dindo Classification of Surgical Complications Five-Year Experience

Pierre A. Clavien et al.

ANNALS OF SURGERY (2009)

Article Medicine, General & Internal

A global clinical measure of fitness and frailty in elderly people

K Rockwood et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)